Atamañuk, Andrés N.
Litewka, Diego F.
Baratta, Sergio J.
Seropian, Ignacio M.
Perez Prados, Graciela
Payaslian, Miguel O.
Ortiz Fragola, Juan P.
Escribano Subias, Pilar
Funding for this research was provided by:
Actelion Pharmaceuticals Ltd
Article History
Received: 28 November 2017
Accepted: 25 November 2019
First Online: 21 December 2019
Ethics approval and consent to participate
: The committee that approved this study was Comite de ética en investigación del Hospital General de Agudos Juan A. Fernández (Research Ethic Committee, Juan A. Fernández General Hospital) (reference number: CEIHF201930). Verbal informed consent was obtained and registered in the clinical record. Consent was obtained verbally because there was no intervention and the study represented no potential harm or danger to the patients. The IRB approved the verbal method of obtaining consent.
: Not applicable.
: The authors declare no conflict of interest.